{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:55:00Z","timestamp":1791330900368,"version":"4.3.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2012,6]]},"abstract":"<jats:p>\n            The renin-angiotensin-aldosterone system is involved in the arterial hypertension-associated cardiovascular remodeling. In this context, the development of cardiac fibrosis results from an imbalance between profibrotic and antifibrotic pathways, in which the role of aldosterone is yet not established. To determine the role of intracardiac aldosterone in the development of myocardial fibrosis during hypertension, we used a double transgenic model (AS-Ren) of cardiac hyperaldosteronism (AS) and systemic hypertension (Ren). The 9-month\u2013old hypertensive mice had cardiac fibrosis, and hyperaldosteronism enhanced the fibrotic level. The mRNA levels of connective tissue growth factor and transforming growth factor-\u03b21 were similarly increased in Ren and AS-Ren mice compared with wild-type and AS mice, respectively. Hyperaldosteronism combined with hypertension favored the macrophage infiltration (CD68\n            <jats:sup>+<\/jats:sup>\n            cells) in heart, and enhanced the mRNA level of monocyte chemoattractant protein 1, osteopontin, and galectin 3. Interestingly, in AS-Ren mice the hypertension-induced increase in bone morphogenetic protein 4 mRNA and protein levels was significantly inhibited, and B-type natriuretic peptide expression was blunted. The mineralocorticoid receptor antagonist eplerenone restored B-type natriuretic peptide and bone morphogenetic protein 4 levels and decreased CD68 and galectin 3 levels in AS-Ren mice. Finally, when hypertension was induced by angiotensin II infusion in wild-type and AS mice, the mRNA profiles did not differ from those observed in Ren and AS-Ren mice, respectively. The aldosterone-induced inhibition of B-type natriuretic peptide and bone morphogenetic protein 4 expression was confirmed in vitro in neonatal mouse cardiomyocytes. Altogether, we demonstrate that, at the cardiac level, hyperaldosteronism worsens hypertension-induced fibrosis through 2 mineralocorticoid receptor-dependent mechanisms, activation of inflammation\/galectin 3\u2013induced fibrosis and inhibition of antifibrotic factors (B-type natriuretic peptide and bone morphogenetic protein 4).\n          <\/jats:p>","DOI":"10.1161\/hypertensionaha.111.190512","type":"journal-article","created":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T05:22:02Z","timestamp":1335849722000},"page":"1179-1187","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":93,"title":["Aldosterone Inhibits Antifibrotic Factors in Mouse Hypertensive Heart"],"prefix":"10.1161","volume":"59","author":[{"given":"Feriel","family":"Azibani","sequence":"first","affiliation":[{"name":"From the Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U942 and Universit\u00e9 Paris-Diderot (F.A., L.B., F.T., L.F., E.P., R.M., J.L.S., C.D.), Paris, France; Lariboisi\u00e8re Hospital AP-HP (J.M.L.), Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U702, Paris, France; University Pierre et Marie Curie (C.C.), Paris, France; Department of Experimental Pharmacology and Toxicology (S.S., L.C.), Cardiovascular Research Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany;..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Benard","sequence":"additional","affiliation":[{"name":"From the Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U942 and Universit\u00e9 Paris-Diderot (F.A., L.B., F.T., L.F., E.P., R.M., J.L.S., C.D.), Paris, France; Lariboisi\u00e8re Hospital AP-HP (J.M.L.), Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U702, Paris, France; University Pierre et Marie Curie (C.C.), Paris, France; Department of Experimental Pharmacology and Toxicology (S.S., L.C.), Cardiovascular Research Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany;..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Schlossarek","sequence":"additional","affiliation":[{"name":"From the Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U942 and Universit\u00e9 Paris-Diderot (F.A., L.B., F.T., L.F., E.P., R.M., J.L.S., C.D.), Paris, France; Lariboisi\u00e8re Hospital AP-HP (J.M.L.), Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U702, Paris, France; University Pierre et Marie Curie (C.C.), Paris, France; Department of Experimental Pharmacology and Toxicology (S.S., L.C.), Cardiovascular Research Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany;..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regine","family":"Merval","sequence":"additional","affiliation":[{"name":"From the Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U942 and Universit\u00e9 Paris-Diderot (F.A., L.B., F.T., L.F., E.P., R.M., J.L.S., C.D.), Paris, France; Lariboisi\u00e8re Hospital AP-HP (J.M.L.), Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U702, Paris, France; University Pierre et Marie Curie (C.C.), Paris, France; Department of Experimental Pharmacology and Toxicology (S.S., L.C.), Cardiovascular Research Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany;..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Tournoux","sequence":"additional","affiliation":[{"name":"From the Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U942 and Universit\u00e9 Paris-Diderot (F.A., L.B., F.T., L.F., E.P., R.M., J.L.S., C.D.), Paris, France; Lariboisi\u00e8re Hospital AP-HP (J.M.L.), Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U702, Paris, France; University Pierre et Marie Curie (C.C.), Paris, France; Department of Experimental Pharmacology and Toxicology (S.S., L.C.), Cardiovascular Research Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany;..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loubina","family":"Fazal","sequence":"additional","affiliation":[{"name":"From the Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U942 and Universit\u00e9 Paris-Diderot (F.A., L.B., F.T., L.F., E.P., R.M., J.L.S., C.D.), Paris, France; Lariboisi\u00e8re Hospital AP-HP (J.M.L.), Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U702, Paris, France; University Pierre et Marie Curie (C.C.), Paris, France; Department of Experimental Pharmacology and Toxicology (S.S., L.C.), Cardiovascular Research Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany;..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Polidano","sequence":"additional","affiliation":[{"name":"From the Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U942 and Universit\u00e9 Paris-Diderot (F.A., L.B., F.T., L.F., E.P., R.M., J.L.S., C.D.), Paris, France; Lariboisi\u00e8re Hospital AP-HP (J.M.L.), Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U702, Paris, France; University Pierre et Marie Curie (C.C.), Paris, France; Department of Experimental Pharmacology and Toxicology (S.S., L.C.), Cardiovascular Research Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany;..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Launay","sequence":"additional","affiliation":[{"name":"From the Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U942 and Universit\u00e9 Paris-Diderot (F.A., L.B., F.T., L.F., E.P., R.M., J.L.S., C.D.), Paris, France; Lariboisi\u00e8re Hospital AP-HP (J.M.L.), Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U702, Paris, France; University Pierre et Marie Curie (C.C.), Paris, France; Department of Experimental Pharmacology and Toxicology (S.S., L.C.), Cardiovascular Research Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany;..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Carrier","sequence":"additional","affiliation":[{"name":"From the Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U942 and Universit\u00e9 Paris-Diderot (F.A., L.B., F.T., L.F., E.P., R.M., J.L.S., C.D.), Paris, France; Lariboisi\u00e8re Hospital AP-HP (J.M.L.), Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U702, Paris, France; University Pierre et Marie Curie (C.C.), Paris, France; Department of Experimental Pharmacology and Toxicology (S.S., L.C.), Cardiovascular Research Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany;..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Chatziantoniou","sequence":"additional","affiliation":[{"name":"From the Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U942 and Universit\u00e9 Paris-Diderot (F.A., L.B., F.T., L.F., E.P., R.M., J.L.S., C.D.), Paris, France; Lariboisi\u00e8re Hospital AP-HP (J.M.L.), Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U702, Paris, France; University Pierre et Marie Curie (C.C.), Paris, France; Department of Experimental Pharmacology and Toxicology (S.S., L.C.), Cardiovascular Research Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany;..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane-Lise","family":"Samuel","sequence":"additional","affiliation":[{"name":"From the Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U942 and Universit\u00e9 Paris-Diderot (F.A., L.B., F.T., L.F., E.P., R.M., J.L.S., C.D.), Paris, France; Lariboisi\u00e8re Hospital AP-HP (J.M.L.), Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U702, Paris, France; University Pierre et Marie Curie (C.C.), Paris, France; Department of Experimental Pharmacology and Toxicology (S.S., L.C.), Cardiovascular Research Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany;..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Delcayre","sequence":"additional","affiliation":[{"name":"From the Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U942 and Universit\u00e9 Paris-Diderot (F.A., L.B., F.T., L.F., E.P., R.M., J.L.S., C.D.), Paris, France; Lariboisi\u00e8re Hospital AP-HP (J.M.L.), Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U702, Paris, France; University Pierre et Marie Curie (C.C.), Paris, France; Department of Experimental Pharmacology and Toxicology (S.S., L.C.), Cardiovascular Research Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany;..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000121426.43044.2b"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.22.2700"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lab.2003.07.004"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00029330-200811010-00016"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000147181.65298.4d"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.107.157677"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm888"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.112222199"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000142858.44680.27"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.08-125302"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature03215"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006721"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.20.2694"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.108.117531"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.104.2.137"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.1993.1066"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.109.131110"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.110.163287"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2008.070726"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","unstructured":"Psarras S Mavroidis M Sanoudou D Davos CH Xanthou G Varela AE Panoutsakopoulou V Capetanaki Y . Regulation of adverse remodelling by osteopontin in a genetic heart failure model. Eur Heart J. July 20 2011. DOI: 10.1161\/HYPERTENSIONAHA.111.190512. http:\/\/eurheartj.oxfordjournals.org\/content\/early\/2011\/04\/26\/eurheartj.ehr119.short. Accessed April 19 2012.","DOI":"10.1161\/HYPERTENSIONAHA.111.190512"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2009.9"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.106.077537"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002243"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/circheartfailure.109.906909"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.11.4104"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2004.08.028"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1545"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.09-146985"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/circheartfailure.110.958033"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000046234.73401.70"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2008.10.154"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature02006"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.19.10.7096"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.236950"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/cdg400"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2009.10.011"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-09-0050"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.111.190512","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T09:44:06Z","timestamp":1715593446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.111.190512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.111.190512"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.111.190512","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"2011-12-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-04-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-04-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}